Jason A Mouabbi

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Metastatic Breast Cancer

Radiation Therapy

Smoking Cessation

Top Venues

NPJ breast cancer

Breast cancer research and treatment

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jason A Mouabbi, Wei Qaio, Yu Shen, Akshara Singareeka Raghavendra, Debasish Tripathy, Rachel M Layman
Efficacy of Single-Agent Chemotherapy in Endocrine Therapy-Refractory Metastatic Invasive Lobular Carcinoma. The oncologist (2023)
Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, Amy Hassan, Debasish Tripathy, Rachel M Layman
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies. NPJ breast cancer 8 (1) (2022)
Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, Amy Hassan, Debasish Tripathy, Rachel M Layman
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies. NPJ breast cancer 8 (1) (2022)
Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, Amy Hassan, Debasish Tripathy, Rachel M Layman
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies. NPJ breast cancer 8 (1) (2022)
Jason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, Amy Hassan, Debasish Tripathy, Rachel M Layman
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies. NPJ breast cancer 8 (1) (2022)
Jason A Mouabbi, Amy Hassan, Bora Lim, Gabriel N Hortobagyi, Debasish Tripathy, Rachel M Layman
Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast cancer research and treatment 193 (2) (2022)
Jason A Mouabbi, Momal Chand, Ishaq A Asghar, Ramen Sakhi, Daniel Ockner, Carrie L Dul, Tarik Hadid, Amr Aref, Mothaffar F Rimawi, Valentina Hoyos
Lumpectomy followed by radiation improves survival in HER2 positive and triple-negative breast cancer with high tumor-infiltrating lymphocytes compared to mastectomy alone. Cancer medicine 10 (14) (2021)
Jason A Mouabbi, C Kent Osborne, Rachel Schiff, Mothaffar F Rimawi
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer. Breast cancer research and treatment 190 (2) (2021)